AOD-9604 offers a gentler approach with more selective fat targeting and fewer systemic effects, making it suitable for individuals who cannot tolerate GLP-1 agonists or prefer a more focused mechanism
By promoting tissue regeneration, stimulating blood vessel formation, and enhancing collagen synthesis, BPC-157 can speed up recovery from injuries and reduce downtime
More on MOTS-c, the mitochondrial peptide we prescribe for metabolic and body composition support
With a result duration of 9-12 months, and over 86% of treated patients saying they would choose Kysse, Kysse is a great choice for both results and cost-effectiveness
HOMA2-IR returns in proportion to regain (about +0.6% at under-25% regain to +39.5% at 50-75%)
A single capsule taken once daily requires minimal lifestyle disruption